QuadPharma QuaDPharma is a GMP contract drug manufacturing company delivering high value to clients in terms of flexibility, responsiveness and relationships heavy on collaboration. Specialties in semi-solids, solids, small-molecules, large molecules, packaging, analytical method development and process optimization drive an engine that continually satisfies the needs of our clients. Founded in 2010 by President & CEO Stephen A. Panaro, Ph.D. QuaDPharma, Inc. was designed from the beginning to serve the needs of the pharmaceutical industry that relates to small-scale pre-commercial and commercial manufacturing. Dr. Panaro has synthesis expertise in Drug Discovery and Pilot Plant scale-up and has used these skills throughout his tenure at APP Pharma and Contract Pharmaceuticals Ltd.